Metabolism Analysis

Effects of rat gut microbiota on the behavior of Realgar in vivo*

Expand
  • School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China

Revised date: 2022-06-11

  Online published: 2024-06-24

Abstract

Objective: To compare the blood pharmacokinetic behavior and urinary and fecal excretion of arsenic in normal and pseudo-sterile rats after oral administration of Realgar to clarify the influence of gut microbiota on the behavior of arsenic from Realgar in vivo. Methods: Rats were divided into normal and pseudo-sterile groups, and the pseudo-sterile rat model was established by oral gavaging of antibiotic mixtures of neomycin sulfate, streptomycin sulfate, and bacitracin.The blood, urine and feces were collected at different time points or periods after oral gavage of Realgar in normal and pseudo-sterile rats, respectively. Total arsenic content was determined by hydride generation atomic fluorescence spectroscopy(HG-AFS). The lamp current and negative pressure of arsenic were 70 mA and 250 V, respectively. The carrier and gasshield flow rate were 400 and 1 000 mL·min-1, respectively. Results: The Tmax of blood arsenic in normal and pseudo-sterile rats were 48.00 and 89.14 h, respectively. The arsenic urinary excretion in normal and pseudo-sterile rats were 76.34 and 41.24 μg, respectively. Compared with the normal rats, the Tmax of blood arsenic in pseudo-sterile rats was significantly increased, and arsenic urinary excretion was significantly reduced within 0-8 h. Conclusion: Gut microbiota accelerates the absorption of arsenic, but has no significant effect on total arsenic concentration, and promotes arsenic urinary excretion within 8 h after administration.

Cite this article

ZHU Hui-lin, LIN Chao, PENG Lin-xiu, WU Xiao . Effects of rat gut microbiota on the behavior of Realgar in vivo*[J]. Chinese Journal of Pharmaceutical Analysis, 2022 , 42(7) : 1153 -1158 . DOI: 10.16155/j.0254-1793.2022.07.07

References

[1] MA W, YUE J, LIANG S, et al. Realgar increases defenses against infection by Enterococcus faecalis in Caenorhabditis elegans[J].J Ethnopharmacol, 2020, 268(11): 113559
[2] 中华人民共和国药典2020年版. 一部[S].2020: 350
ChP 2020. VolⅠ[S].2020: 350
[3] 王丹, 王莉, 徐锐, 等. 纳米雄黄对单纯疱疹病毒Ⅱ型的体外抗病毒活性[J].中南大学学报, 2019, 44(10):1143
WANG D, WANG L, XU R, et al. Antiviral activity of nano-Realgar against herpes simplex virus type Ⅱ in vitro[J].J Cent South Univ, 2019, 44(10):1143
[4] XI XX, SUN J, XI DB, et al. Realgar nanoparticles inhibit migration, invasion and metastasis in a mouse model of breast cancer by suppressing matrix metalloproteinases and angiogenesis[J].Curr Drug Deliv, 2020, 17(2): 148
[5] CHEN P, XU RX, YAN L, et al. Properties of Realgar bioleaching using an extremely acidophilic bacterium and its antitumor mechanism as an anticancer agent[J].Biol Res, 2017, 50(1): 17
[6] KHAIRUL I, WANG QQ, JIANG YH, et al. Metabolism, toxicity and anticancer activities of arsenic compounds[J].Oncotarget, 2017, 8(14):23905
[7] 孙宇婷, 徐焕华, 聂窈, 等. 雄黄及三氧化二砷对小鼠肠道菌群的初步探究[J].中国中药杂志, 2020, 45(1):142
SUN YT, XU HH, NIE Y, et al. Preliminary study of Realgar and arsenic trioxide on gut microbiota of mice[J].China J Chin Mater Med, 2020, 45(1):142
[8] CORYELL M, MCALPINE M, PINKHAM NV, et al. The gut microbiome is required for full protection against acute arsenic toxicity in mouse models[J].Nat Commun, 2018, 9(1): 5424
[9] GUO MH, WANG WJ, HAI X, et al. HPLC-HG-AFS determination of arsenic species in acute promyelocytic leukemia(APL) plasma and blood cells[J].J Pharm Biomed Anal, 2017, 145:356
[10] MARSCHNER K, MUSIL S, DěDINA J. Achieving 100% efficient postcolumn hydride generation for as speciation analysis by atomic fluorescence spectrometry[J].Anal Chem, 2016, 88(7):4041
[11] LEE SH, AN JH, LEE HJ, et al. Evaluation of pharmacokinetic differences of acetaminophen in pseudo germ-free rats[J].Biopharm Drug Dispos, 2012, 33(6):292
[12] BHOWMIK SK, AN JH, LEE SH, et al. Alteration of bile acid metabolism in pseudo germ-free rats[corrected][J].Arch Pharm Res, 2012, 35(11):1969
[13] WU X, WU S, LIU Y, et al. Health risk assessment of arsenic in Realgar and Niuhuangjiedu tablets based on pharmacokinetic study[J].J Trace Elem Med Biol, 2018, 48:81
[14] WU X, GUAN R, LIU Y, et al. Comparative health risk assessment of Realgar and Niuhuangjiedu tablets based on tissue arsenic levels after multiple oral administration to rats[J].J Ethnopharmacol, 2019, 249:112370
[15] UJANG T, SADLER R, NG J, et al. Bioavailability study of arsenic and mercury in traditional Chinese medicines(TCM) using an animal model after a single dose exposure[J].Regul Toxicol Pharmacol, 2016, 76: 51
[16] FENG YH, HUANG YL, WANG Y, et al. Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy[J].PLoS One, 2019, 14(6): e0218384
[17] 宋媛媛, 贡雪芃, 肖蒙, 等. 抗生素相关性腹泻研究进展[J].医药导报, 2019, 38(11):1454
SONG YY, GONG XP, XIAO M, et al. Research progress of antibiotic associated diarrhea[J].Her Med, 2019, 38(11):1454
Outlines

/